vs
BALCHEM CORP（BCPC）与亨斯迈（HUN）财务数据对比。点击上方公司名可切换其他公司
亨斯迈的季度营收约是BALCHEM CORP的5.1倍（$1.4B vs $263.6M）。BALCHEM CORP净利率更高（14.9% vs -7.1%，领先22.0%）。BALCHEM CORP同比增速更快（9.8% vs -6.7%）。过去两年BALCHEM CORP的营收复合增速更高（4.9% vs -4.0%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
亨斯迈公司是总部位于美国得克萨斯州伍德兰兹的全球化化工巨头，面向消费端与工业客户生产、销售各类化工产品，主营聚氨酯、高性能材料及胶粘剂，客户覆盖宝马、通用电气、雪佛龙、宝洁、联合利华等知名品牌。目前公司在全球25个国家设有60余处生产、研发及运营基地，员工约7000人。
BCPC vs HUN — 直观对比
营收规模更大
HUN
是对方的5.1倍
$263.6M
营收增速更快
BCPC
高出16.5%
-6.7%
净利率更高
BCPC
高出22.0%
-7.1%
两年增速更快
BCPC
近两年复合增速
-4.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $1.4B |
| 净利润 | $39.2M | $-96.0M |
| 毛利率 | 35.6% | 12.1% |
| 营业利润率 | 19.8% | -4.4% |
| 净利率 | 14.9% | -7.1% |
| 营收同比 | 9.8% | -6.7% |
| 净利润同比 | 16.8% | 31.9% |
| 每股收益（稀释后） | $1.21 | $-0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCHUN
| Q4 25 | $263.6M | $1.4B | ||
| Q3 25 | $267.6M | $1.5B | ||
| Q2 25 | $255.5M | $1.5B | ||
| Q1 25 | $250.5M | $1.4B | ||
| Q4 24 | $240.0M | $1.5B | ||
| Q3 24 | $239.9M | $1.5B | ||
| Q2 24 | $234.1M | $1.6B | ||
| Q1 24 | $239.7M | $1.5B |
净利润BCPCHUN
| Q4 25 | $39.2M | $-96.0M | ||
| Q3 25 | $40.3M | $-25.0M | ||
| Q2 25 | $38.3M | $-158.0M | ||
| Q1 25 | $37.1M | $-5.0M | ||
| Q4 24 | $33.6M | $-141.0M | ||
| Q3 24 | $33.8M | $-33.0M | ||
| Q2 24 | $32.1M | $22.0M | ||
| Q1 24 | $29.0M | $-37.0M |
毛利率BCPCHUN
| Q4 25 | 35.6% | 12.1% | ||
| Q3 25 | 35.7% | 14.0% | ||
| Q2 25 | 36.4% | 12.5% | ||
| Q1 25 | 35.2% | 14.3% | ||
| Q4 24 | 36.0% | 12.9% | ||
| Q3 24 | 35.6% | 15.2% | ||
| Q2 24 | 35.5% | 15.4% | ||
| Q1 24 | 34.0% | 13.7% |
营业利润率BCPCHUN
| Q4 25 | 19.8% | -4.4% | ||
| Q3 25 | 20.4% | 0.4% | ||
| Q2 25 | 20.1% | -8.2% | ||
| Q1 25 | 20.4% | 3.0% | ||
| Q4 24 | 19.8% | -4.3% | ||
| Q3 24 | 20.0% | 2.7% | ||
| Q2 24 | 19.6% | 2.2% | ||
| Q1 24 | 17.4% | -2.6% |
净利率BCPCHUN
| Q4 25 | 14.9% | -7.1% | ||
| Q3 25 | 15.1% | -1.7% | ||
| Q2 25 | 15.0% | -10.8% | ||
| Q1 25 | 14.8% | -0.4% | ||
| Q4 24 | 14.0% | -9.7% | ||
| Q3 24 | 14.1% | -2.1% | ||
| Q2 24 | 13.7% | 1.4% | ||
| Q1 24 | 12.1% | -2.5% |
每股收益（稀释后）BCPCHUN
| Q4 25 | $1.21 | $-0.56 | ||
| Q3 25 | $1.24 | $-0.14 | ||
| Q2 25 | $1.17 | $-0.92 | ||
| Q1 25 | $1.13 | $-0.03 | ||
| Q4 24 | $1.03 | $-0.82 | ||
| Q3 24 | $1.03 | $-0.19 | ||
| Q2 24 | $0.98 | $0.13 | ||
| Q1 24 | $0.89 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $429.0M |
| 总债务越低越好 | — | $2.0B |
| 股东权益账面价值 | $1.3B | $2.8B |
| 总资产 | $1.7B | $7.0B |
| 负债/权益比越低杠杆越低 | — | 0.73× |
8季度趋势，按日历期对齐
现金及短期投资BCPCHUN
| Q4 25 | $74.6M | $429.0M | ||
| Q3 25 | $65.1M | $468.0M | ||
| Q2 25 | $65.4M | $399.0M | ||
| Q1 25 | $49.9M | $334.0M | ||
| Q4 24 | $49.5M | $340.0M | ||
| Q3 24 | $73.7M | $330.0M | ||
| Q2 24 | $63.7M | $335.0M | ||
| Q1 24 | $60.3M | $552.0M |
总债务BCPCHUN
| Q4 25 | — | $2.0B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | — | $1.9B | ||
| Q1 24 | — | $2.1B |
股东权益BCPCHUN
| Q4 25 | $1.3B | $2.8B | ||
| Q3 25 | $1.3B | $2.8B | ||
| Q2 25 | $1.3B | $2.8B | ||
| Q1 25 | $1.2B | $3.0B | ||
| Q4 24 | $1.1B | $3.0B | ||
| Q3 24 | $1.2B | $3.1B | ||
| Q2 24 | $1.1B | $3.1B | ||
| Q1 24 | $1.1B | $3.2B |
总资产BCPCHUN
| Q4 25 | $1.7B | $7.0B | ||
| Q3 25 | $1.7B | $7.1B | ||
| Q2 25 | $1.7B | $7.1B | ||
| Q1 25 | $1.6B | $7.2B | ||
| Q4 24 | $1.6B | $7.1B | ||
| Q3 24 | $1.6B | $7.3B | ||
| Q2 24 | $1.6B | $7.3B | ||
| Q1 24 | $1.6B | $7.6B |
负债/权益比BCPCHUN
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 0.73× | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.62× | ||
| Q3 24 | — | 0.60× | ||
| Q2 24 | — | 0.62× | ||
| Q1 24 | — | 0.65× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $76.0M |
| 自由现金流经营现金流 - 资本支出 | — | $19.0M |
| 自由现金流率自由现金流/营收 | — | 1.4% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | $116.0M |
8季度趋势，按日历期对齐
经营现金流BCPCHUN
| Q4 25 | $67.3M | $76.0M | ||
| Q3 25 | $65.6M | $196.0M | ||
| Q2 25 | $47.3M | $91.0M | ||
| Q1 25 | $36.5M | $-74.0M | ||
| Q4 24 | $52.3M | $153.0M | ||
| Q3 24 | $51.3M | $129.0M | ||
| Q2 24 | $45.0M | $46.0M | ||
| Q1 24 | $33.4M | $-65.0M |
自由现金流BCPCHUN
| Q4 25 | — | $19.0M | ||
| Q3 25 | — | $153.0M | ||
| Q2 25 | — | $54.0M | ||
| Q1 25 | — | $-110.0M | ||
| Q4 24 | — | $102.0M | ||
| Q3 24 | — | $88.0M | ||
| Q2 24 | — | $-4.0M | ||
| Q1 24 | — | $-107.0M |
自由现金流率BCPCHUN
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 10.5% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | -7.8% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 5.7% | ||
| Q2 24 | — | -0.3% | ||
| Q1 24 | — | -7.3% |
资本支出强度BCPCHUN
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | — | 2.6% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.9% |
现金转化率BCPCHUN
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | 2.09× | ||
| Q1 24 | 1.15× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
HUN
| Diversified | $897.0M | 66% |
| Specialty | $231.0M | 17% |
| Performance Products | $113.0M | 8% |
| Advanced Materials | $61.0M | 5% |
| Related Party Customers | $19.0M | 1% |
| Other | $12.0M | 1% |
